Treatment Information

Until the FDA rescinds its current Partial Administrative Clinical Hold on the Burzynski Clinic, the FDA Expanded Access for compassionate IND is likely the only way to obtain Antineoplastons. Below is a description and application link. We recommend consulting with ANP Coalition Inc. prior to doing so, but that is certainly not an application requirement.

 Application Process for Expanded Access

Access to Investigational Drugs (Expanded Access)

This link describes what constitutes clinical trial phases;


The following is a list of cancer ANP has shown efficacy in.

The ANP Coalition has had personal contact with patients who have medically confirmed efficacy ranging from a reduction in tumor to complete responses in the following types of cancer as a result of treatment utilizing ANP;

Brain Tumors;
-Anaplastic Astrocytoma
-Glioblastoma Multiforme
-Astrocytoma, low grade
-Pilocytoc Astrocytoma
-PNET medulloblastoma
-Desmoplastic Infantile Ganglioglioma
-Pilocytic, involvement of pons
-Ependymoma / spinal tumor
-Malignant Meningioma
-Tectal Glioma & astrocytoma, low grade
-Astrocytoma of the Brain stem, Midbrain, Thalamus and Hypothalamus
-Brainstem Glioma
-Diffuse Intrinsic Brainstem Glioma, with features of Anaplastic Astrocytoma
-Visual Pathway Astrocytoma
-Anaplastic Astrocytoma of the Brainstem

Breast Cancer
Kidney Cancer
Multiple Myeloma
Non-Hodgkin’s Lymphoma
Prostate Cancer
Anal Cancer
Biliary Tract
Carcinoma of Unknown Primary
Carcinoma of the left anterior upper chest wall with metastasis to the mammary lymph nodes
Colon Cancer
Esophageal / Stomach Cancer
Head and Neck Cancer
Chronic Lymphocytic Leukemia
Lung Cancer
Malignant Melanoma
Malignant Melanoma with mets
Ovarian Cancer
Prostate with mets to lungs
Small Intestine Cancer
Urothelial High Grade (Bladder)
Uterine, Cervix, Vulvar, Endometrium